Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Vicente Bebia is a leading gynecologic oncologist whose research centers on optimizing surgical staging and sentinel lymph node mapping for gynecologic cancers, particularly endometrial and cervical malignancies. His most impactful work challenges conventional practices: the COMBITEC study (19 citations) demonstrated that combining indocyanine green (ICG) with technetium-99m does not improve sentinel lymph node detection in endometrial cancer, streamlining intraoperative protocols. Dr. Bebia has been instrumental in advancing laparoscopic extraperitoneal paraaortic lymphadenectomy, showing through a landmark Spanish multicenter study (17 citations) that this approach provides critical prognostic information in locally advanced cervical cancer. His comparative analyses (16 citations) reveal that extraperitoneal access reduces surgical complications versus transperitoneal routes in ovarian and endometrial cancers, while a post hoc analysis of the STELLA-2 trial (15 citations) confirms that robotic-assisted extraperitoneal paraaortic lymphadenectomy further minimizes morbidity. By systematically evaluating surgical techniques and staging strategies, Dr. Bebia’s work has directly influenced clinical guidelines, improving patient outcomes through evidence-based, minimally invasive approaches. His collaborative multicenter studies underscore his role as a key figure in refining the surgical management of gynecologic malignancies.